Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ON7G
|
|||
Drug Name |
Isoxazole-based bicyclic compound 3
|
|||
Synonyms |
PMID26924192-Compound-63
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ZENITH EPIGENETICS CORP
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H18N4O2
|
|||
Canonical SMILES |
CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)N(C(=O)N3)CC4=CC=CC=C4)N
|
|||
InChI |
1S/C19H18N4O2/c1-11-17(12(2)25-22-11)14-8-15(20)18-16(9-14)23(19(24)21-18)10-13-6-4-3-5-7-13/h3-9H,10,20H2,1-2H3,(H,21,24)
|
|||
InChIKey |
HWHJKVNNLYESRW-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
KEGG Pathway | SNARE interactions in vesicular transport | |||
Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.